Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2006-08-01
2006-08-01
O'Hara, Eileen B. (Department: 1646)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S320100, C435S252330, C435S361000, C435S348000, C435S255100, C530S350000, C536S023500, C514S012200
Reexamination Certificate
active
07083949
ABSTRACT:
The present invention provides a fusion polypeptide that forms a multimer that is capable of binding a cytokine to form a nonfunctional complex. It also provides a nucleic acid sequence encoding the fusion polypeptide and methods of making and uses for the fusion polypeptide.
REFERENCES:
patent: 5470952 (1995-11-01), Stahl et al.
patent: 6210661 (2001-04-01), Enssle et al.
patent: 6472179 (2002-10-01), Stahl et al.
patent: 0835939 (1991-06-01), None
patent: 0533006 (1992-09-01), None
patent: WO93/19163 (1993-09-01), None
patent: WO93/19777 (1993-10-01), None
patent: WO94/22914 (1994-10-01), None
patent: WO95/06737 (1995-03-01), None
patent: WO96/11213 (1996-04-01), None
patent: WO96/23881 (1996-08-01), None
patent: WO96/35783 (1996-11-01), None
patent: WO97/15669 (1997-05-01), None
patent: WO97/31946 (1997-09-01), None
patent: WO99/37772 (1999-07-01), None
Barnes, Journal of Clinical Immunology and Allergy. Aug. 2001, vol. 108, Issue 2, part 2, pp. S72-S76.
The Physicians Desk Reference (PDR, electronic version).
J. of Biol. Chem., 1995, Greenfeeder, S.A., et al., “Molecular Cloning and Characterization of a Second Subunit of the Interleukin 1 Receptor Complex”, 270(23):13757-13765.
Biochem and Biophys Res Comm, 1997, Seipelt, I., et al., “Overexpression, Purification, and Use of a Soluble Human Interleukin-4 Receptor α-chain/Igy1 Fusion Protein for Ligand Binding Studies,” 239:534-542.
FASEB Journal, 1999, Stahl,N., et al., “Cytokine Traps: Heteromeric Receptor-Based Protein Therapeutics that Function as High-Affinity Blockers of Cytokine Action,” Abstract, 1457.
Stahl Neil
Yancopoulos George D.
Gregg, Esq. Valeta
O'Hara Eileen B.
Regeneron Pharmaceuticals Inc.
LandOfFree
Receptor based antagonists and methods of making and using does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Receptor based antagonists and methods of making and using, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Receptor based antagonists and methods of making and using will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3711900